¿Aún no está registrado?

Información relevante

Consulte los artículos y contenidos publicados en éste medio, además de los e-sumarios de las revistas científicas en el mismo momento de publicación

Máxima actualización

Esté informado en todo momento gracias a las alertas y novedades

Promociones exclusivas

Acceda a promociones exclusivas en suscripciones, lanzamientos y cursos acreditados

* = Required fields

Enter your email address

User name *

Clínica e Investigación en Arteriosclerosis (English Edition)

Suscribe to the journal

Clínica e Investigación en Arteriosclerosis (English Edition) Most often read

Clínica e Investigación en Arteriosclerosis (English Edition)

ISSN: 2529-9123

Clínica e Investigación en Arteriosclerosis is the official journal of the Spanish Society of Arteriosclerosis, the Latinoamerican Society of Arteriosclerosis and the Iberolatinoamerican Society of Arteriosclerosis. The journal is the leading Spanish written peer-review journal in the field of arteriosclerosis and its related risk factors. The aim of the journal is primarily the promotion of knowledge and continued medical education, with a special focus in the Spanish-speaking audience, through the publication of relevant research contributions, basic and clinical, in the field and the publication of review and update articles.

See more Open Access Option

Indexed in:

Web of Science, Index Medicus/MEDLINE, Scopus, IBECS, IME, MEDES

See more

Follow us

X

Contact

Email

Subscribe

Tienda

Alert

Newsletter

Impact factor

The Impact Factor measures the average number of citations received in a particular year by papers published in the journal during the two preceding years.

© Clarivate Analytics, Journal Citation Reports 2025

See more

Impact factor 2025

1.9

Citescore

CiteScore measures average citations received per document published.

See more

Citescore 2024

3.7

SJR

SRJ is a prestige metric based on the idea that not all citations are the same. SJR uses a similar algorithm as the Google page rank; it provides a quantitative and qualitative measure of the journal's impact.

See more

SJR 2024

0.502

SNIP

SNIP measures contextual citation impact by wighting citations based on the total number of citations in a subject field.

See more

SNIP 2024

0.694

View more metrics

Journal Information

Most often read

Vol. 38. Issue. 4

12452

Recommendations of the Spanish Arteriosclerosis Society: The diet in cardiovascular prevention - 2024 Update

Emilio Ros, Pablo Pérez-Martínez, Ramón Estruch, José López-Miranda, Cristina Soler Ferrer, Javier Delgado-Lista, Francisco Gómez-Delgado, Rosa Solà, Vicente Pascual

Clin Investig Arterioscler. 2025;37:

12452

Full text access

Open Article

Share

2599

Evidence on cardiovascular prevention with icosapent ethyl

Jose Luis Díaz-Díaz

Clin Investig Arterioscler. 2025;37 Supl 1:

2599

Full text access

Open Article

Share

2477

Cumulative exposure to cholesterol: Lost time cannot be recovered

Pablo Pérez-Martínez, José López-Miranda

Clin Investig Arterioscler. 2025;37:

2477

Full text access

Open Article

Share

2451

Icosapent ethyl: From the REDUCE-IT trial to clinical practice

Juan Pedro-Botet

Clin Investig Arterioscler. 2025;37 Supl 1:

2451

Full text access

Open Article

Share

1989

Analysis of lipoprotein (a) determination in a selection of Spanish Clinical Laboratories. Batary study

Teresa Arrobas Velilla, Salomon Martin Perez, Carla Fernández Prendes, Maria Jose Castro Castro, Silvia Camos Anguila, Antonio Leon Justel

Clin Investig Arterioscler. 2025;37:

1989

Full text access

Open Article

Share

1633

Efficiency of fixed-dose combinations of statin and ezetimibe in the treatment of hypercholesterolemia

Carlos Guijarro, Angel Diaz, Eva Moreno, Paula Gamonal, Maria Soler, Neus Vidal-Vilar, Maria Rosa Fernandez

Clin Investig Arterioscler. 2025;37:

1633

Full text access

Open Article

Share

1405

Strategies to improve cardiovascular health and treatment of dyslipidemia in Spain. Expert Insights Project

Juan Pedro-Botet, Román Freixa, Juan José Tamarit, José López-Miranda, Rosa Fernández-Olmo, Ovidio Muñiz-Grijalvo, Rafael Vázquez-García, Carlos Guijarro, ... Juan Cosín-Sales

Clin Investig Arterioscler. 2025;37:

1405

Full text access

Open Article

Share

1373

COPD and cardiovascular risk

Carlos Santiago Díaz, Francisco J. Medrano, N. Muñoz-Rivas, Luis Castilla Guerra, M. Belén Alonso Ortiz

Clin Investig Arterioscler. 2025;37:

1373

Share

1305

How to achieve LDL cholesterol goals with the funding criteria for new lipid-lowering drugs?

Antón González-Guerrero, Elisenda Climent, David Benaiges, Juan Pedro Botet

Clin Investig Arterioscler. 2025;37:

1305

Full text access

Open Article

Share

1236

Hypertriglyceridemia (> 150 mg/dL) as a marker of cardiovascular risk

José López-Miranda

Clin Investig Arterioscler. 2025;37 Supl 1:

1236

Full text access

Open Article

Share

1208

Efficacy and safety of PCSK9 inhibitors in real life

Antón González-Guerrero, Eugenia Navarrete-Rouco, David Benaiges, Eva Giralt-Steinhauer, Lidia Marcos, Anna Oliveras, Lluis Recasens, Juan Pedro-Botet

Clin Investig Arterioscler. 2025;37:

1208

Share

1185

Treatment of hypertriglyceridemia to reduce cardiovascular risk

Carlos Guijarro Hérraiz

Clin Investig Arterioscler. 2025;37 Supl 1:

1185

Full text access

Open Article

Share

1161

Comparison of baseline clinical characteristics among people with type 2 diabetes on second-line therapy previously added with dapagliflozin or another oral glucose-lowering drug: AGORA study

Vicente Pallarés-Carratalá, Antonio Ruiz-García, Adalberto Serrano-Cumplido, Antonio Segura Fragoso, Verónica Fernández-Pascual, Beatriz Sánchez-Sánchez, María Inmaculada Cervera-Pérez, Francisco Javier Alonso-Moreno, ... on behalf of the Investigators of the AGORA study, of the Spanish Society of Primary Care Physicians SEMERGEN Foundation

Clin Investig Arterioscler. 2025;37:

1161

Full text access

Open Article

Share

1136

Usefulness of body and visceral fat determined by bioimpedancemetry versus body mass index and waist circumference in the identification of elevated values of different atherogenesis risk scales

María Gordito Soler, José Ignacio Ramírez-Manent, Pedro Juan Tárraga López, Emilio Martínez-Almoyna Rifá, Hernán Paublini, Ángel Arturo López González

Clin Investig Arterioscler. 2025;37:

1136

Share

1086

Nutritional habits in patients with peripheral arterial disease: Adherence to the Mediterranean diet

Elena Vilalta Doñate, Francisca García Fernández, Salvador Martínez Meléndez, Consuelo Castillo Castillo, Pablo Salas Medina, Isabel Almodóvar Fernández

Clin Investig Arterioscler. 2025;37:

1086

Full text access

Open Article

Share

1043

Cardiovascular prevention studies in a population with hypertriglyceridemia

Ovidio Muñiz-Grijalvo

Clin Investig Arterioscler. 2025;37 Supl 1:

1043

Full text access

Open Article

Share

1000

The complexity of cardiovascular risk in women. Descriptive review

J. Ildefonzo Arocha Rodulfo, Gestne Aure Fariñez

Clin Investig Arterioscler. 2025;37:

1000

Full text access

Open Article

Share

1000

Interferon stimulated gene 15 (ISG15) modulates phenotype of vascular smooth muscle cells and pathological vascular remodelling

Julius Soudant, Raquel González-Blázquez, Abraham Merino, Constanza Ballesteros-Martínez, Raquel Rodrigues-Diez, Rosa Moreno-Carriles, J. Francisco Nistal, Susana Guerra, ... Ana B. García-Redondo

Clin Investig Arterioscler. 2025;37:

1000

Share

999

Correlation of the adhesion of the elements of atheroma and the causes of thrombosis

Irving Mauricio Lecona Licona, José María Rodríguez Lelis, Joaquín Pérez Ortega, José Alfredo Rodríguez Ramírez

Clin Investig Arterioscler. 2025;37:

999

Full text access

Open Article

Share

946

Polygenic risk and subclinical atherosclerosis in asymptomatic middle-aged individuals. The ILERVAS study

Emilio Ortega, Amanda Jiménez, Sheila López-Ruiz, Eva Castro-Boqué, José Manuel Valdivielso, Marcelino Bermúdez-López, Gemma Chiva-Blanch

Clin Investig Arterioscler. 2025;37:

946

Full text access

Open Article

Share

asdasdasd

Ayúdenos a conocerle mejor, indíquenos por favor su especialidad:

Help us get to know you better by telling us your specialty: